Mayorga C. Fernandez T.D. Montañez M.I. et al.

Recent developments and highlights in drug hypersensitivity.

Allergy. 74: 2368-2381

Diagnosis and management of anaphylaxis in precision medicine.

J Allergy Clin Immunol. 140: 321-333Gomes E.S.R. Marques M.L. Regateiro F.S.

Epidemiology and Risk Factors for Severe Delayed Drug Hypersensitivity Reactions.

Curr Pharm Des. 25: 3799-3812Metcalfe D.D. Peavy R.D. Gilfillan A.M.

Mechanisms of mast cell signaling in anaphylaxis.

J Allergy Clin Immunol. 124 (): 639-646

Mast cells--key effector cells in immune responses.

Trends Immunol. 28: 234-241

IgE and mast cells in allergic disease.

Nat Med. 18: 693-704Navinés-Ferrer A. Serrano-Candelas E. Lafuente A. et al.

MRGPRX2-mediated mast cell response to drugs used in perioperative procedures and anaesthesia.

Sci Rep. 8: 11628Ebo D.G. Clarke R.C. Mertes P.M. et al.

Molecular mechanisms and pathophysiology of perioperative hypersensitivity and anaphylaxis: a narrative review.

Br J Anaesth. 123: e38-e49Spoerl D. D'Incau S. Roux-Lombard P. et al.

Non-IgE-Dependent Hypersensitivity to Rocuronium Reversed by Sugammadex: Report of Three Cases and Hypothesis on the Underlying Mechanism.

Int Arch Allergy Immunol. 169: 256-262Porebski G. Kwiecien K. Pawica M. et al.

Mas-Related G Protein-Coupled Receptor-X2 (MRGPRX2) in Drug Hypersensitivity Reactions.

Front Immunol. 9: 3027

Revisiting the role of MRGPRX2 on hypersensitivity reactions to neuromuscular blocking drugs.

Curr Opin Immunol. 72: 65-71Jönsson F. de Chaisemartin L. Granger V. et al.

An IgG-induced neutrophil activation pathway contributes to human drug-induced anaphylaxis.

Sci Transl Med. 11McNeil B.D. Pundir P. Meeker S. et al.

Identification of a mast-cell-specific receptor crucial for pseudo-allergic drug reactions.

Nature. 519: 237-241Tatemoto K. Nozaki Y. Tsuda R. et al.

Immunoglobulin E-independent activation of mast cell is mediated by Mrg receptors.

Biochem Biophys Res Commun. 349: 1322-1328Motakis E. Guhl S. Ishizu Y. et al.

Redefinition of the human mast cell transcriptome by deep-CAGE sequencing.

Blood. 123: e58-e67Varricchi G. Pecoraro A. Loffredo S. et al.

Heterogeneity of Human Mast Cells With Respect to MRGPRX2 Receptor Expression and Function.

Front Cell Neurosci. 13: 299Manorak W. Idahosa C. Gupta K. et al.

Upregulation of Mas-related G Protein coupled receptor X2 in asthmatic lung mast cells and its activation by the novel neuropeptide hemokinin-1.

Respir Res. 19: 1Plum T. Wang X. Rettel M. et al.

Human Mast Cell Proteome Reveals Unique Lineage, Putative Functions, and Structural Basis for Cell Ablation.

Immunity. 52: 404-416 e405Chen E. Chuang L.S. Giri M. et al.

Inflamed Ulcerative Colitis Regions Associated With MRGPRX2-Mediated Mast Cell Degranulation and Cell Activation Modules, Defining a New Therapeutic Target.

Gastroenterology. 160: 1709-1724Wedi B. Gehring M. Kapp A.

The pseudoallergen receptor MRGPRX2 on peripheral blood basophils and eosinophils: Expression and function.

Allergy. 75: 2229-2242Sabato V. Elst J. Van Houdt M. et al.

Surface expression of MRGPRX2 on resting basophils: An area of controversy.

Allergy. 75: 2421-2422Babina M. Wang Z. Roy S. et al.

MRGPRX2 Is the Codeine Receptor of Human Skin Mast Cells: Desensitization through β-Arrestin and Lack of Correlation with the FcεRI Pathway.

J Invest Dermatol. 141: 1286-1296.e4Jiang W. Hu S. Che D. et al.

A mast-cell-specific receptor mediates Iopamidol induced immediate IgE-independent anaphylactoid reactions.

Int Immunopharmacol. 75: 105800Wolf K. Kühn H. Boehm F. et al.

A group of cationic amphiphilic drugs activates MRGPRX2 and induces scratching behavior in mice.

J Allergy Clin Immunol. 48: 506-522.e8Pham T.D.M. Ziora Z.M. Blaskovich M.A.T.

Quinolone antibiotics.

Medchemcomm. 10: 1719-1739Doña I. Moreno E. Pérez-Sánchez N. et al.

Update on Quinolone Allergy.

Curr Allergy Asthma Rep. 17: 56McGee E.U. Samuel E. Boronea B. et al.

Quinolone Allergy.

Pharmacy (Basel). 7Blanca-López N. Andreu I. Torres Jaén M.J.

Hypersensitivity reactions to quinolones.

Curr Opin Allergy Clin Immunol. 11: 285-291Giavina-Bianchi P. Goncalves D.G. Zanandrea A. et al.

Anaphylaxis to quinolones in mastocytosis: Hypothesis on the mechanism.

J Allergy Clin Immunol Pract. 7: 2089-2090Liu R. Hu S. Zhang Y. et al.

Mast cell-mediated hypersensitivity to fluoroquinolone is MRGPRX2 dependent.

Int Immunopharmacol. 70: 417-427Han S. Lv Y. Kong L. et al.

Use of the relative release index for histamine in LAD2 cells to evaluate the potential anaphylactoid effects of drugs.

Sci Rep. 7: 13714Elst J. Sabato V. Faber M.A. et al.

MRGPRX2 and Immediate Drug Hypersensitivity: Insights from Cultured Human Mast Cells.

J Investig Allergol Clin Immunol. 0Elst J. Maurer M. Sabato V. et al.

Novel Insights on MRGPRX2-Mediated Hypersensitivity to Neuromuscular Blocking Agents And Fluoroquinolones.

Front Immunol. 12: 668962Liu C. Bayer A. Cosgrove S.E. et al.

Clinical practice guidelines by the infectious diseases society of america for the treatment of methicillin-resistant Staphylococcus aureus infections in adults and children: executive summary.

Clin Infect Dis. 52: 285-292Savoldi A. Azzini A.M. Baur D. et al.

Is there still a role for vancomycin in skin and soft-tissue infections?.

Curr Opin Infect Dis. 31: 120-130

MRGPRX2 and Adverse Drug Reactions.

Front Immunol. 12: 676354

Vancomycin revisited - 60 years later.

Front Public Health. 2: 217Alvarez-Arango S. Ogunwole S.M. Sequist T.D. et al.

Vancomycin Infusion Reaction - Moving beyond “Red Man Syndrome”.

N Engl J Med. 384: 1283-1286

Red man syndrome.

Crit Care. 7: 119-120Azimi E. Reddy V.B. Lerner E.A.

Brief communication: MRGPRX2, atopic dermatitis and red man syndrome.

Itch (Phila). 2: e5Grimes J. Desai S. Charter N.W. et al.

MrgX2 is a promiscuous receptor for basic peptides causing mast cell pseudo-allergic and anaphylactoid reactions.

Pharm Res. 7: e00547Alvarez-Arango S. Oliver E. Tang O. et al.

Vancomycin immediate skin responses in vancomycin-naïve subjects.

Clin Exp Allergy. 51: 932-935Veien M. Szlam F. Holden J.T. et al.

Mechanisms of nonimmunological histamine and tryptase release from human cutaneous mast cells.

Anesthesiology. 92: 1074-1081Fujisawa D. Kashiwakura J. Kita H. et al.

Expression of Mas-related gene X2 on mast cells is upregulated in the skin of patients with severe chronic urticaria.

J Allergy Clin Immunol. 134: 622-633 e629Polk R.E. Israel D. Wang J. et al.

Vancomycin skin tests and prediction of “red man syndrome” in healthy volunteers.

Antimicrob Agents Chemother. 37: 2139-2143Mertes P.M. Alla F. Tréchot P. et al.

Anaphylaxis during anesthesia in France: an 8-year national survey.

J Allergy Clin Immunol. 128: 366-373

Life-threatening anaphylactoid reactions to muscle relaxants.

Anesth Analg. 62: 559-564Van Gasse A.L. Elst J. Bridts C.H. et al.

Rocuronium Hypersensitivity: Does Off-Target Occupation of the MRGPRX2 Receptor Play a Role?.

J Allergy Clin Immunol Pract. 7: 998-1003Subramanian H. Gupta K. Ali H.

Roles of Mas-related G protein-coupled receptor X2 on mast cell-mediated host defense, pseudoallergic drug reactions, and chronic inflammatory diseases.

J Allergy Clin Immunol. 138: 700-710Che D. Rui L. Cao J. et al.

Cisatracurium induces mast cell activation and pseudo-allergic reactions via MRGPRX2.

Int Immunopharmacol. 62: 244-250Che D. Wang J. Ding Y. et al.

Mivacurium induce mast cell activation and pseudo-allergic reactions via MAS-related G protein coupled receptor-X2.

Cell Immunol. 332: 121-128Fernandopulle N.A. Zhang S.S. Soeding P.F. et al.

MRGPRX2 activation in mast cells by neuromuscular blocking agents and other agonists: Modulation by sugammadex.

Clin Exp Allergy. 51: 685-695Mertes P.M. Moneret-Vautrin D.A. Leynadier F. et al.

Skin reactions to intradermal neuromuscular blocking agent injections: a randomized multicenter trial in healthy volunteers.

Anesthesiology. 107: 245-252Levy J.H. Gottge M. Szlam F. et al.

Weal and flare responses to intradermal rocuronium and cisatracurium in humans.

Br J Anaesth. 85: 844-849Shtessel M. Limjunyawong N. Oliver E.T. et al.

MRGPRX2 Activation Causes Increased Skin Reactivity in Patients with Chronic Spontaneous Urticaria.

J Invest Dermatol. 141: 678-681.e672Petitpain N. Argoullon L. Masmoudi K. et al.

Neuromuscular blocking agents induced anaphylaxis: Results and trends of a French pharmacovigilance survey from 2000 to 2012.

Allergy. 73: 2224-2233Reddy J.I. Cooke P.J. van Schalkwyk J.M. et al.

Anaphylaxis is more common with rocuronium and succinylcholine than with atracurium.

Anesthesiology. 122: 39-45Sadleir P.H. Clarke R.C. Bunning D.L. et al.

Anaphylaxis to neuromuscular blocking drugs: incidence and cross-reactivity in Western Australia from 2002 to 2011.

Br J Anaesth. 110: 981-987Suzuki Y. Liu S. Kadoya F. et al.

Association between mutated Mas-related G protein-coupled receptor-X2 and rocuronium-induced intraoperative anaphylaxis.

Br J Anaesth. 125: e446-e448Lansu K. Karpiak J. Liu J. et al.

In silico design of novel probes for the atypical opioid receptor MRGPRX2.

Nat Chem Biol. 13: 529-536Chompunud Na Ayudhya C. Amponnawarat A. Roy S. et al.

MRGPRX2 Activation by Rocuronium: Insights from Studies with Human Skin Mast Cells and Missense Variants.

Cells. 10Bruhns P. Chollet-Martin S.

Mechanisms of human drug-induced anaphylaxis.

J Allergy Clin Immunol. 147: 1133-1142

Allergic reactions to drugs: implications for perioperative care.

J Perianesth Nurs. 17: 393-398Casale T.B. Bowman S. Kaliner M.

Induction of human cutaneous mast cell degranulation by opiates and endogenous opioid peptides: evidence for opiate and nonopiate receptor participation.

J Allergy Clin Immunol. 73: 775-781Sheen C.H. Schleimer R.P. Kulka M.

Codeine induces human mast cell chemokine and cytokine production: involvement of G-protein activation.

Allergy. 62: 532-538Harle D.G. Baldo B.A. Coroneos N.J. et al.

Anaphylaxis following administration of papaveretum. Case report: Implication of IgE antibodies that react with morphine and codeine, and identification of an allergenic determinant.

Anesthesiology. 71: 489-494

Emerging Roles for MAS-Related G Protein-Coupled Receptor-X2 in Host Defense Peptide, Opioid, and Neuropeptide-Mediated Inflammatory Reactions.

Adv Immunol. 136: 123-162

Neuraxial opioid-induced pruritus: An update.

J Anaesthesiol Clin Pharmacol. 29: 303-307

Histamine-releasing and allergenic properties of opioid analgesic drugs: resolving the two.

Anaesth Intensive Care. 40: 216-235Hutchinson M.R. Shavit Y. Grace P.M. et al.

Exploring the neuroimmunopharmacology of opioids: an integrative review of mechanisms of central immune signaling and their implications for opioid analgesia.

Pharmacol Rev. 63: 772-810Lawrence I.D. Warner J.A. Cohan V.L. et al.

Purification and characterization of human skin mast cells. Evidence for human mast cell heterogeneity.

J Immunol. 139: 3062-3069Tharp M.D. Kagey-Sobotka A. Fox C.C. et al.

Functional heterogeneity of human mast cells from different anatomic sites: in vitro responses to morphine sulfate.

J Allergy Clin Immunol. 79: 646-653Liu X.Y. Liu Z.C. Sun Y.G. et al.

Unidirectional cross-activation of GRPR by MOR1D uncouples itch and analgesia induced by opioids.

Cell. 147: 447-458Liu R. Wang J. Zhao T. et al.

Relationship between MRGPRX2 and pethidine hydrochloride- or fentanyl citrate-induced LAD2 cell degranulation.

J Pharm Pharmacol. 70: 1596-1605Reich A. Szepietowski J.C.

Opioid-induced pruritus: an update.

Clin Exp Dermatol. 35: 2-6Dinges H.C. Otto S. Stay D.K. et al.

Side Effect Rates of Opioids in Equianalgesic Doses via Intravenous Patient-Controlled Analgesia: A Systematic Review and Network Meta-analysis.

Anesth Analg. 129: 1153-1162

Anaphylaxis to radiographic contrast media.

Curr Opin Allergy Clin Immunol. 11: 326-331Kim M.H. Park C.H. Kim D.I. et al.

Surveillance of contrast-media-induced hypersensitivity reactions using signals from an electronic medical recording system.

Ann Allergy Asthma Immunol. 108: 167-171Kim S.R. Lee J.H. Park K.H. et al.

Varied incidence of immediate adverse reactions to low-osmolar non-ionic iodide radiocontrast media used in computed tomography.

Clin Exp Allergy. 47: 106-112

X-ray contrast media--an overview.

Toxicology. 209: 185-187Morales-Cabeza C. Roa-Medellín D. Torrado I. et al.

Immediate reactions to iodinated contrast media.

Ann Allergy Asthma Immunol. 119: 553-557

Immediate and delayed reactions to radiocontrast media: is there an allergic mechanism?.

Immunol Allergy Clin N Am. 29: 453-468Trcka J. Schmidt C. Seitz C.S. et al.

Anaphylaxis to iodinated contrast material: nonallergic hypersensitivity or IgE-mediated allergy?.

AJR Am J Roentgenol. 190: 666-670Dewachter P. Laroche D. Mouton-Faivre C. et al.

Immediate reactions following iodinated contrast media injection: a study of 38 cases.

Eur J Radiol. 77: 495-501Kim M.H. Lee S.Y. Lee S.E. et al.

Anaphylaxis to iodinated contrast media: clinical characteristics related with development of anaphylactic shock.

PLoS One. 9: e100154Chung S.J. Kang D.Y. Lee W. et al.

HLA-DRB1∗15: 02 Is Associated With Iodinated Contrast Media-Related Anaphylaxis.

Invest Radiol. 55: 304-309Lumry W.R. Li H.H. Levy R.J. et al.

Randomized placebo-controlled trial of the bradykinin B₂ receptor antagonist icatibant for the treatment of acute attacks of hereditary angioedema: the FAST-3 trial.

Ann Allergy Asthma Immunol. 107: 529-537Bas M. Greve J. Stelter K. et al.

A randomized trial of icatibant in ACE-inhibitor-induced angioedema.

N Engl J Med. 372: 418-425Sinert R. Levy P. Bernstein J.A. et al.

Randomized Trial of Icatibant for Angiotensin-Converting Enzyme Inhibitor-Induced Upper Airway Angioedema.

J Allergy Clin Immunol Pract. 5: 1402-1409 e1403Liu R. Che D. Zhao T. et al.

MRGPRX2 is essential for sinomenine hydrochloride induced anaphylactoid reactions.

Biochem Pharmacol. 146: 214-223Huang L. Dong Y. Wu J. et al.

Sinomenine-induced histamine release-like anaphylactoid reactions are blocked by tranilast via inhibiting NF-κB signaling.

Pharmacol Res. 125: 150-160Okamura Y. Mishima S. Kashiwakura J.I. et al.

The dual regulation of substance P-mediated inflammation via human synovial mast cells in rheumatoid arthritis.

Allergol Int. 66S: S9-S20Rouzaire P. Nosbaum A. Mullet C. et al.

Immediate allergic hypersensitivity to quinolones associates with neuromuscular blocking agent sensitization.

J Allergy Clin Immunol Pract. 1: 273-279 e271Baldo B.A. Fisher M.M. Pham N.H.

On the origin and specificity of antibodies to neuromuscular blocking (muscle relaxant) drugs: an immunochemical perspective.

Clin Exp Allergy. 39: 325-344Babina M. Wang Z. Franke K. et al.

Thymic Stromal Lymphopoietin Promotes MRGPRX2-Triggered Degranulation of Skin Mast Cells in a STAT5-Dependent Manner with Further Support from JNK.

Cells. 10

Mastocytosis and Anaphylaxis.

Immunol Allergy Clin North Am. 37: 153-164Deepak V. Komarow H.D. Alblaihess A.A. et al.

Expression of MRGPRX2 in skin mast cells of patients with maculopapular cutaneous mastocytosis.

J Allergy Clin Immunol Pract. 9: 3841-3843.e1Hermans M.A.W. Arends N.J.T. Gerth van Wijk R. et al.

Management around invasive procedures in mastocytosis: An update.

Ann Allergy Asthma Immunol. 119: 304-309Doña I. Blanca-López N. Boteanu C. et al.

Clinical Practice Guidelines for Diagnosis and Management of Hypersensitivity Reactions to Quinolones.

J Investig Allergol Clin Immunol. 31: 292-307Roy S. Chompunud Na Ayudhya C. Thapaliya M. et al.

Multifaceted MRGPRX2: New insight into the role of mast cells in health and disease.

J Allergy Clin Immunol. 148: 293-308Alkanfari I. Gupta K. Jahan T. et al.

Naturally Occurring Missense MRGPRX2 Variants Display Loss of Function Phenotype for Mast Cell Degranulation in Response to Substance P, Hemokinin-1, Human beta-Defensin-3, and Icatibant.

J Immunol. 201: 343-349Chompunud Na Ayudhya C. Roy S. Alkanfari I. et al.

Identification of Gain and Loss of Function Missense Variants in MRGPRX2's Transmembrane and Intracellular Domains for Mast Cell Activation by Substance P.

Int J Mol Sci. 20

Minireview: Mas-related G protein-coupled receptor X2 activation by therapeutic drugs.

Neurosci Lett. 751: 135746Ansotegui I.J. Melioli G. Canonica G.W. et al.

IgE allergy diagnostics and other relevant tests in allergy, a World Allergy Organization position paper.

World Allergy Organ J. 13: 100080Broyles A.D. Banerji A. Castells M.

Practical Guidance for the Evaluation and Management of Drug Hypersensitivity: General Concepts.

J Allergy Clin Immunol Pract. 8: S3-S15Mayorga C. Celik G. Rouzaire P. et al.

In vitro tests for drug hypersensitivity reactions: an ENDA/EAACI Drug Allergy Interest Group position paper.

Allergy. 71: 1103-1134Elst J. Sabato V. Hagendorens M.M. et al.

Measurement and Functional Analysis of the Mas-Related G Protein-Coupled Receptor MRGPRX2 on Human Mast Cells and Basophils.

Methods Mol Biol. 2163: 219-226Ebo D.G. Elst J. Van Gasse A. et al.

Basophil Activation Experiments in Immediate Drug Hypersensitivity: More Than a Diagnostic Aid.

Methods Mol Biol. 2163: 197-211Ebo D.G. Van der Poorten M.L. Elst J. et al.

Immunoglobulin E cross-linking or MRGPRX2 activation: clinical insights from rocuronium hypersensitivity.

Br J Anaesth. 126: e27-e29Elst J. van der Poorten M.M. Van Gasse A.L. et al.

Mast cell activation tests by flow cytometry: A new diagnostic asset?.

Clin Exp Allergy. 51: 1482-1500

Drug allergy: an updated practice parameter.

Ann Allergy Asthma Immunol. 105: 259-273Azimi E. Reddy V.B. Shade K.C. et al.

Dual action of neurokinin-1 antagonists on Mas-related GPCRs.

JCI Insight. 1: e89362Mencarelli A. Gunawan M. Yong K.S.M. et al.

A humanized mouse model to study mast cells mediated cutaneous adverse drug reactions.

J Leukoc Biol. 107: 797-807Ogasawara H. Furuno M. Edamura K. et al.

Novel MRGPRX2 antagonists inhibit IgE-independent activation of human umbilical cord blood-derived mast cells.

J Leukoc Biol. 106: 1069-1077Suzuki Y. Liu S. Ogasawara T. et al.

A novel MRGPRX2-targeting antagonistic DNA aptamer inhibits histamine release and prevents mast cell-mediated anaphylaxis.

Eur J Pharmacol. 878: 173104Callahan B.N. Kammala A.K. Syed M. et al.

Osthole, a Natural Plant Derivative Inhibits MRGPRX2 Induced Mast Cell Responses.

Front Immunol. 11: 703Kumar M. Singh K. Duraisamy K. et al.

Protective Effect of Genistein against Compound 48/80 Induced Anaphylactoid Shock via Inhibiting MAS Related G Protein-Coupled Receptor X2 (MRGPRX2).

Molecules. 25Ding Y. Che D. Li C. et al.

Quercetin inhibits Mrgprx2-induced pseudo-allergic reaction via PLCγ-IP3R related Ca(2+) fluctuations.

Int Immunopharmacol. 66: 185-197Wang J. Zhang Y. Li C. et al.

Inhibitory function of Shikonin on MRGPRX2-mediated pseudo-allergic reactions induced by the secretagogue.

Phytomedicine. 68: 153149